BioSpace News Archive

Drug Development

Exelixis Announces Amendment to Clinical Research Protocol for Phase Ib Trial of Cabozantinib in Combination with Atezolizumab in Patients with Locally Advanced or Metastatic Solid Tumors

Exelixis today announced an amendment to the protocol for the phase 1b trial of cabozantinib in combination with atezolizumab (TECENTRIQ) in patients with locally advanced or metastatic solid tumors.

January 4, 2018
·
17 min read
Drug Development

Cortexyme Initiates Phase I Clinical Development of COR388, a Promising Potential Treatment for Alzheimer’s and Other Degenerative Diseases

Cortexyme today announced the first cohort has been dosed in the initial trial of its phase 1 clinical development program for COR388, the company’s lead compound.

January 4, 2018
·
3 min read
Drug Development

Tosk Reports Initiation of POC Human Studies

Tosk, Inc. reported today the completion of Phase 1 safety trials and the initiation of POC studies in human cancer patients for the prevention of mucositis side effects using its drug TK-90.

January 4, 2018
·
2 min read
Business

Adaptive Biotechnologies Announces Partnership with Microsoft to Decode the Human Immune System to Improve the Diagnosis of Disease

Adaptive Biotechnologies announced today their partnership with Microsoft to map the genetics of the human immune system, or immunome, in order to detect cancers and other diseases in their earliest stage, when they can be more effectively treated.

January 4, 2018
·
4 min read
BioMidwest

Monsanto Spotlights Research & Development Pipeline Projects to Help Farmers Combat Threats, Optimize Opportunities and Conserve Natural Resources

This marks the fifth consecutive year that more than 20 projects advanced in the pipeline.

January 4, 2018
·
12 min read
Business

Pierre Fabre Enters Worldwide Licensing Agreement with Boston Pharmaceuticals for a Selective Potassium Channel Blocker for Atrial Fibrillation

Pierre Fabre Pharmaceuticals (Pierre Fabre) and Boston Pharmaceuticals Inc. (Boston Pharmaceuticals) today announced they have entered into a worldwide licensing agreement for Pierre Fabre’s selective potassium channel blocker, F17727.

January 4, 2018
·
4 min read
Acasti Expands Global Patent Portfolio with Newly Granted Patents in South Korea and Canada

Acasti today announced the granting of a patent by the South Korean Patent Office and the granting of a corresponding patent by the Canadian Intellectual Property Office, further strengthening the international intellectual property position of CaPre.

January 4, 2018
·
4 min read
German Biotech BioNTech Locks in $270M Series A

The Company previously completed a seed round fundraising in 2008 concurrent with its founding.

January 4, 2018
·
2 min read
Business

Effective April 1, 2018: OraSure CEO to Retire, New Leader Named

The Company also announced updated revenue guidance for the fourth quarter of 2017.

January 4, 2018
·
10 min read
Biotech Beach

NuVasive Gets Expanded FDA OK, Launches Interbody Fusion Devices

The launch and updated claims follow NuVasive’s September 2017 acquisition of Vertera Spine.

January 4, 2018
·
4 min read